Rapid and Sensitive LC-MS/MS Method for Quantification of Fexofenadine in Human Plasma——Application to a Bioequivalence Study in Chinese Volunteers

被引:0
作者
TENG Guo-sheng1
3.Department of Pharmacy
机构
关键词
Fexofenadine; Bioequivalence; LC-MS/MS; Human plasma;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
A rapid and sensitive liquid chromatography-tandem mass spectrometry method(LC-MS/MS)was developed and validated for the quantification of fexofenadine in human plasma,to conduct comparative bioavailability studies.Human plasma was extracted with a mixture of dichloromethane-diethyl ether(volume ratio 2∶3)in a basic environment and the extract was separated on a C18 column with a mobile phase consisting of acetonitrile-methanol-10 mmol/L ammonium acetate(volume ratio 45∶45∶10).The analytes were detected via electrospray ionization(ESI)tandem mass spectrometry in the multiple-reaction-monitoring(MRM)mode.The linearity was within a range of 1-1000 ng/mL.The intra-and inter-day precision were<4.1% and<4.8%,respectively,and the accuracy was in the range of 95.0%-105%.The method was applied to the quantification of fexofenadine human plasma from 20 healthy male Chinese volunteers,according to a single dose,randomized,two-way crossover design with a two-week washout period.The mean values of major pharmacokinetic parameters of ρmax,AUC0-48,AUC0-∞,tmax,and t1/2 were determined from the plasma concentration.The analysis of variance(ANOVA)did not show any significant difference between the two products of fexofenadine and 90% confidence intervals fell within the acceptable range for bioequivalence.
引用
收藏
页码:514 / 517
页数:4
相关论文
共 11 条
  • [1] Coutant J.E,Westmark P.A,Nardella P.A.et al. Journal of Chromatography . 1991
  • [2] Surapaneni S,Khalil S.K.W. Journal of Liquid Chromatography . 1994
  • [3] Uno T,Yasui-Furukori N,Takahata T.et al. J.Pharm.Biomed.Anal . 2004
  • [4] Robbins D.K,Castles M.A,Pack D.J.et al. Drug Dis-pos . 1998
  • [5] Hofmann U,Seiler M,Drescher S.et al. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences . 2002
  • [6] Fu I,Woolf E.J,Matuszewski B.K. J.Pharm.Biomed.Anal . 2004
  • [7] Nirogi R.V.S,Kandikere K.N,Shukla M.et al. Biomed.Chromatogr . 2007
  • [8] Nirogi R.V.S,Kandikere K.N,Shukla M.et al. Rapid Communications in Mass Spectrometry . 2006
  • [9] Fromm M.F. Int.J.Clin.Pharmacol.Ther . 2000
  • [10] Simpson K,Jarvis B. Drugs . 2000